William K. Oh, M.D. is the Chief of the Division of Hematology and Medical Oncology; Professor of Medicine and Urology; and Ezra M. Greenspan, MD Professor in Clinical Cancer Therapeutics at the Mount Sinai School of Medicine and Associate Director for Clinical Research, The Tisch Cancer Institute.
Dr. Oh's clinical interests include: Management of genitourinary malignancies, including prostate, renal, bladder, adrenocortical and testicular cancers.
Dr. Oh's research interests include exploring the role of chemotherapy in both castration-resistant prostate cancer (CRPC) and localized high-risk prostate cancer. In collaboration with laboratory-based colleagues, we are assessing changes in the expression of tissue and serum biomarkers due to chemotherapy. Another area of interest relates to the role of secondary hormone therapies in the treatment of advanced prostate cancer.
Visit Dr. William Oh here, http://bit.ly/11AJxku
Dr. William Oh on Treatment Choices for Prostate Cancer neurology department | |
| 3 Likes | 3 Dislikes |
| 464 views views | 36K followers |
| Education | Upload TimePublished on 26 Feb 2013 |
Không có nhận xét nào:
Đăng nhận xét